Scoring criteria
Each candidate gets a four-axis score.
Axes
- Immunogenicity - predicted MHC binding and T-cell activation.
- Selectivity - distance from human self-peptidome.
- Stability - proteolytic half-life and aggregation propensity.
- Manufacturability - solid-phase synthesizability and yield.
Why one platform spans many diseases
Programmable substrate, modular targets.
300+
Diseases addressable from a shared design framework
5
Disease families being explored as initial targets
Rapid prediction-to-synthesis cycle.